KQ-2003

· Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KQ-2003, covering 2024-01-25 to 2024-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

See pricing